Cargando…

Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up

Although fluoroquinolones are first-line agents for the treatment of National Institutes of Health (NIH) category II chronic bacterial prostatitis (CBP), therapy with these agents is not always feasible due to the increasing worldwide resistance of causative uropathogens. New therapeutic options are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magri, Vittorio, Montanari, Emanuele, Marras, Emanuela, Perletti, Gianpaolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038489/ https://www.ncbi.nlm.nih.gov/pubmed/27698761 http://dx.doi.org/10.3892/etm.2016.3631

Ejemplares similares

Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients
por: MAGRI, VITTORIO, et al.
Publicado: (2015)

Commentary: Pharmacological Interventions for Bacterial Prostatitis
por: Magri, Vittorio, et al.
Publicado: (2020)

One, No One and One Hundred Thousand: Patterns of chronic prostatic inflammation and infection
por: Stamatiou, Konstantinos, et al.
Publicado: (2021)

Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
por: MAGRI, V., et al.
Publicado: (2013)

Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients
por: VRAL, A., et al.
Publicado: (2012)

Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study
por: Cai, Tommaso, et al.
Publicado: (2017)

Spectrum of Causative Pathogens and Resistance Rates to Antibacterial Agents in Bacterial Prostatitis
por: Trinchieri, Alberto, et al.
Publicado: (2021)

Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance to Aminoglycoside Antibiotics
por: Wang, Nuoyan, et al.
Publicado: (2022)

The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons
por: Vandersickel, Veerle, et al.
Publicado: (2010)

Anti-Cancer Potential of Edible/Medicinal Mushrooms in Breast Cancer
por: Gariboldi, Marzia Bruna, et al.
Publicado: (2023)

Hypoionic shock treatment enables aminoglycosides antibiotics to eradicate bacterial persisters
por: Jiafeng, Liu, et al.
Publicado: (2015)

Ototoxicity of Non-aminoglycoside Antibiotics
por: Rybak, Leonard P., et al.
Publicado: (2021)

Rescoring the NIH Chronic Prostatitis Symptom Index (NIH-CPSI): Nothing New
por: Clemens, J. Quentin, et al.
Publicado: (2009)

DNA-Aptamers Binding Aminoglycoside Antibiotics
por: Nikolaus, Nadia, et al.
Publicado: (2014)

Selective condensation of DNA by aminoglycoside antibiotics
por: Kopaczynska, M., et al.
Publicado: (2015)

Parallel pathways in the biosynthesis of aminoglycoside antibiotics
por: Yu, Yi, et al.
Publicado: (2017)

Aminoglycoside Antibiotics Inhibit Mycobacteriophage Infection
por: Jiang, Zheng, et al.
Publicado: (2020)

Host metabolites stimulate the bacterial proton motive force to enhance the activity of aminoglycoside antibiotics
por: Crabbé, Aurélie, et al.
Publicado: (2019)

Targeting Bacterial Cardiolipin Enriched Microdomains: An Antimicrobial Strategy Used by Amphiphilic Aminoglycoside Antibiotics
por: El Khoury, Micheline, et al.
Publicado: (2017)

The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study
por: Cai, Tommaso, et al.
Publicado: (2021)

Aminoglycoside antibiotics and autism: a speculative hypothesis
por: Manev, Radmila, et al.
Publicado: (2001)

The Supramolecular Self‐Assembly of Aminoglycoside Antibiotics and their Applications
por: Jadhav, Ratan W., et al.
Publicado: (2019)

The relationship between the structure and toxicity of aminoglycoside antibiotics
por: Jospe-Kaufman, Moriah, et al.
Publicado: (2020)

Translation error clusters induced by aminoglycoside antibiotics
por: Wohlgemuth, Ingo, et al.
Publicado: (2021)

Laccase-Catalyzed Derivatization of Aminoglycoside Antibiotics and Glucosamine
por: Mikolasch, Annett, et al.
Publicado: (2022)

Late‐Stage Modification of Aminoglycoside Antibiotics Overcomes Bacterial Resistance Mediated by APH(3’) Kinases
por: Bastian, Andreas A., et al.
Publicado: (2022)

Metabolite-Enabled Eradication of Bacterial Persisters by Aminoglycosides
por: Allison, Kyle R., et al.
Publicado: (2011)

Oxidative Activity of Copper(II) Complexes with Aminoglycoside Antibiotics as Implication to the Toxicity of These Drugs
por: Szczepanik, Wojciech, et al.
Publicado: (2004)

Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside Antibiotics
por: Stoltenburg, Regina, et al.
Publicado: (2012)

Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance
por: Shi, Kun, et al.
Publicado: (2013)

4′-O-substitutions determine selectivity of aminoglycoside antibiotics
por: Perez-Fernandez, Déborah, et al.
Publicado: (2014)

Potentiating aminoglycoside antibiotics to reduce their toxic side effects
por: Rosenberg, Christopher R., et al.
Publicado: (2020)

Advances in the Application of Aptamer Biosensors to the Detection of Aminoglycoside Antibiotics
por: Luan, Yunxia, et al.
Publicado: (2020)

Potential for the Development of a New Generation of Aminoglycoside Antibiotics
por: Tevyashova, A. N., et al.
Publicado: (2022)

Mechanistic insights into translation inhibition by aminoglycoside antibiotic arbekacin
por: Parajuli, Narayan Prasad, et al.
Publicado: (2021)

Analysis of Aminoglycoside Antibiotics: A Challenge in Food Control
por: Nowacka-Kozak, Ewelina, et al.
Publicado: (2023)

Sanguinarine synergistically potentiates aminoglycoside‐mediated bacterial killing
por: Lu, Chang, et al.
Publicado: (2022)

Binding of aminoglycoside antibiotics to helix 69 of 23S rRNA
por: Scheunemann, Ann E., et al.
Publicado: (2010)

Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors
por: Zárate, Sandra G., et al.
Publicado: (2018)

Overcoming Multidrug‐Resistant MRSA Using Conventional Aminoglycoside Antibiotics
por: Tan, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_crmjtr1vlhsrt3l3mr9ft2suea